Stories, blogs and articles

Filter By
Topics

All

About us

Artificial Intelligence

Biotech

Corporate Sustainability

Digitization

Disease Awareness

Fertility

Financials and Company Performance

Gene Editing

Growth Markets

Healthcare

High Tech Materials

Immunology

Lab Materials

Life Sciences and Lab Support

OLED Technologies

Oncology and Immuno-Oncology

Partnerships

People and Employee Development

Pharma and Biopharma End-to-End Manufacturing

Scientific Research

Technology

Well Being

Types

All

Perspectives

Scientific Research

Trends and Innovations

Updates from our Company

Reset All

Showing 1 - 10 of 65 results

2021 Research Grants

2021 research grants advancing the fields of Healthcare and Life Sciences. Send in your proposal for the chance to join our deep dive workshops and advance the proposals further with our scientists.

Cultured Meat

Cell-cultured meat and seafood could provide a healthier, more ethical and sustainable alternative to conventional animal protein. As technology enabler, we aim to accelerate the emerging field of cultured meat

Gene Editing and Gene Therapy

Pioneering biotech company Tocagen developed a cutting-edge, cancer-fighting gene therapy drug. As an experienced manufacturing partner, MilliporeSigma helps get the drug to patients quickly.

Q3 2021: “Big 3” Again Deliver Efficient, Double-Digit Growth

Group again grew strongly in the third quarter of 2021. Net sales amounted to € 5.0 billion. EBITDA pre, the most important financial indicator to steer operating business, reached € 1.6 billion.

The future has never been brighter or more colorful.

Imagine a phone you can fold up and put in your pocket. This might sound like science fiction, but the work of OLED manufacturers and their research partners means that possibility is just around the corner.

Annual Report 2021

On March 3, 2022, we will publish the results of the fourth quarter and fiscal year 2021 at 7 a.m. (CET).

Quarterly Statement Q2/2022

Our Q2 2022 results will be published on August 4, at 7 a.m. (CEST). Our conference call for the media will take place at 9:30 a.m. (CEST), and the conference call for analysts at 2 p.m. (CEST).

Quarterly Statement Q1/2022

Our Q1 2022 results will be published on May 12, at 7 a.m. (CEST). Our conference call for the media will take place at 9:30 a.m. (CEST), and the conference call for analysts at 2 p.m. (CEST).

Innovation Cup

The brightest students from all over the world meet at our company headquarters to learn from professionals, network, develop business plans and win the 20,000 EUR Innovation Cup.

1

2

3

4

5

6

7

1

2

3

4

5

Next